Country websites

CAPD

stay•safe
Dialysis designed around life

Empower patients to perform daily CAPD treatment in an effective and simple way

DISCLAIMER

Not all products and services are cleared or available for sale in all EU countries. Check your country web site for details. 

Dialysis designed around life

  • For patient profiles with varying capabilities.
  • With intuitive operation and simple instructions.
  • Patients are supported to manage CAPD independently at home.

stay•safe system

Potentially reduces the daily treatment burden of your patient due to simplified process steps.

 

  • The stay•safe DISC facilitates simple and effective patient training with its intuitive operation.1
  • The stay•safe PIN may reduce potential accidental contamination into the catheter extension and subsequent infection by reducing the system openings by 50%.*
  • The stay•safe Organizer simplifies and streamlines the CAPD treatment for patients.1,2
  • The PIN technology and Organizer are used across our entire  PD portfolio for seamless transition between CAPD and APD.

 

* The stay•safe system requires four system openings (connections and disconnections from treatment) per day, resulting in approximately 1,460 risk steps per year. In contrast, other conventional systems involve both four connections and four disconnections daily, totaling about 2,920 risk steps annually. These calculations are based on four exchanges per day.

stay•safe DISC

Intuitive simple operation for different patients

 
Designed for convenience, facilitating effective patient training and proper procedure1
 
  • Streamlines the patient training with its intuitive operation and handling.
  • No manual clamping or breaking frangible required.
  • Potentially reduces the risk steps and user errors that could contribute to touch contamination.

4 simple steps to perform CAPD

stay•safe PIN technology

Improve safety by automatically sealing the fluid pathway prior to catheter extension disconnection

 
  • Reduces potential accidental contamination into the catheter extension and subsequent infection.
  • Eliminates 1,460 risk steps per patient / year.*
  • Number of stay•safe system openings is reduced by 50%.*

 

* The stay•safe system requires four system openings (connections and disconnections from treatment) per day, resulting in approximately 1,460 risk steps per year. In contrast, other conventional systems involve both four connections and four disconnections daily, totaling about 2,920 risk steps annually. These calculations are based on four exchanges per day.

 

System stay•safe system Other systems
System openings/day: 4 8
Risk steps/year: 1,460 2,920

 

*  Calculated on the basis of four exchanges/day, as compared to other conventional systems. System openings defined as connections and disconnections from treatment.

stay•safe Organizer

Enhanced convenience with a centralized system to bring all parts of the stay•safe system together

 
  • Simplifies the patient’s role in the CAPD exchange procedure1,2 which can help to improve compliance
  • Can be used on the infusion pole with an appropriate holder, but also on a table without support, for the ease and convenience of patients.

Invitingly simple support

Getting started with CAPD

We support you with a range of specific trainings that lay the foundation for a confident start to therapy. And while everybody is preparing, we help to make sure that everything is up and running in your patients’ homes.

2

Preparation

Train

  • Clearly structured digital and non-digital trainings for nurses and patients to support you
  • The real-life stay•safe MyTraining VR supports a smooth start to the  treatment
  • Nutritional trainings to sideline therapy start

Start

  • A team of experts help to coordinate home setup
  • Starter kit with information on how to set up a home unit for Healthcare Professionals (HCPs)

Preparing patients as good as possible for home dialysis – learn more about our stay•safe MyTraining VR.

The stay•safe MyTraining VR is currently only available in a limited number of countries. Please contact your local Fresenius Medical Care representative to find out more.

The color codes

The color coding clearly identifies the strengths of glucose and calcium of Fresenius Medical Care’s peritoneal dialysis solutions.

A braille system utilizing cutouts identifies the different glucose strengths.

Color coding for glucose strength as well for calcium strength.

Colored caps identify the glucose strength on the bags.

Glucose 1,5%

Glucose 2,3%

Glucose 4,25%

Expect more of us - CAPD monitoring and support

Once therapy has started, we offer a wide range of tools and services aiming to improve outcomes, reduce your workload and increase patient compliance. 

3

Treatment

Support

  • An easy order process in combination with personal phone support ensures that patients can order materials anytime and anywhere. The service is not available in all countries.
  • The delivery service ensures that PD solutions and disposables are delivered straight to your patient’s doorstep.
  • The PD travel service enables patients to continue travelling as the required goods are directly sent to the patient’s holiday destination.

Monitor

  • Remote therapy management with kinexus PD may support monitoring, since healthcare professionals have the opportunity to view treatment data remotely after completion of treatment, and adjust the prescription if needed.
  • Streamlined PD therapy management through easy accessibility to therapy information via our PatientOnLine tool.

DISCLAIMER

Not all products and services are cleared or available for sale in all EU countries. Check your country web site for details. 

Related content

1 Lambert MC, Lage C, Kirchgessner J. stay•safe. A new PVC free system in long-term CAPD treatment. EDTNA ERCA J. 1999; 25(3): 30-34. 

2 L i PK, Law MC, Chow KM, et al. Comparison of clinical outcome and ease of handling in two double-bag systems in continuous ambulatory peritoneal dialysis: A prospective, randomized, controlled, multicenter study. Am J Kidney Dis. 2002; 40(2): 373-380.